Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Genetic polymorphisms as new predictive factors for successful treatment of chronic hepatitis C].

Klinicka mikrobiologie a infekcni lekarstvi - 1 Dec 2011

Válková Ivana, Kristian Pavol, Schréter Ivan, Habalová Viera

Abstract excerpt

Currently, the gold standard for the treatment of chronic hepatitis C is combination therapy with pegylated interferon alpha and ribavirin. Despite advances in treatment modalities, only 50 % of patients achieve sustained virological response. Therefore, determination of predictive factors related to response to therapy is very important. In 2009, three independent studies concerning genome-wide association...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferons

Share to Interleukins

Share to Polyethylene Glycols

Share to Ribavirin

Source

Identifiers

PMID: 22247028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Genetic polymorphisms as new predictive factors for successful treatment of chronic hepatitis C].PMID 22247028Read ↗

[Genetic polymorphisms as predictors of response to antiviral treatment in chronic hepatitis C virus infection].Semantic proximity Read ↗

[Genetic variation of IL-28B is associated with treatment response of patients with chronic hepatitis C].Semantic proximity Read ↗

IL28B polymorphism -- predictive factor of HCV infected genotype 1 individuals to treatment response and management of therapy.Semantic proximity Read ↗

[Role of IL-28B SNPs in the treatment and prognosis of HCV infection].Semantic proximity Read ↗

[IL28B genetic variation and hepatic ISGs expression predict treatment efficacy of IFN-based anti-viral therapy for chronic hepatitis C].Semantic proximity Read ↗

Role of viral and host factors in interferon based therapy of hepatitis C virus infection.Semantic proximity Read ↗

Genetic predictors of the response to the treatment of hepatitis C virus infection.Semantic proximity Read ↗

Novel findings for the development of drug therapy for various liver diseases: Genetic variation in IL-28B is associated with response to the therapy for chronic hepatitis C.Semantic proximity Read ↗

[Association of interleukin 28B polymorphisms with response to pegylatedinterferon plus ribavirin therapy for chronic hepatitis C].Semantic proximity Read ↗

[Genome-wide association studies].Semantic proximity Read ↗

Hepatitis C pharmacogenetics: State of the art in 2010Semantic proximity Read ↗

The role of genetic markers in hepatitis C virus therapy: a major step for individualized care.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.